₹276.25-6.85 (-2.42%)
04:01 PM, 19-Dec-2024₹276.48-6.92 (-2.44%)
03:49 PM, 19-Dec-2024BSE : 540701
NSE : DCAL
Sector : Health care
ISIN Code : INE385W01011
Last Updated: 19-Dec-2024 | 04:01 PM IST
Market Cap (₹ Cr) | 4,332 |
Traded Value (₹ Cr) | 4.28 |
Volume (Shares) | 1,54,858 |
Face Value (₹) | 2 |
52-Week High (₹) | 307.80 |
52-Week High Date | 11-Dec-2024 |
52-Week Low (₹) | 132.75 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 396.55 |
All Time High Date | 25-Jan-2018 |
All Time Low (₹) | 46.45 |
All Time Low Date | 30-Mar-2020 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 4,335 |
EPS - TTM (₹) [C] | 0.00 |
P/E Ratio (X) [C] | - |
Face Value (₹) | 2 |
Latest Dividend (%) | 10.00 |
Latest Dividend Date | 12-Sep-2019 |
Dividend Yield (%) | - |
Book Value Share (₹) [C] | 365.90 |
P/B Ratio (₹) [C] | 0.76 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HSBC Flexi Cap Fund (IDCW) | 36.11 | 14,76,000 | 0.72 |
HSBC Flexi Cap Fund - Direct (G) | 36.11 | 14,76,000 | 0.72 |
HSBC Flexi Cap Fund - Direct (IDCW) | 36.11 | 14,76,000 | 0.72 |
HSBC Flexi Cap Fund (G) | 36.11 | 14,76,000 | 0.72 |
Motilal Oswal Nifty Microcap 250 Index Fund-Reg (G) | 3.75 | 1,53,241 | 0.21 |
Motilal Oswal Nifty Microcap 250 Index Fund-Dir (G) | 3.75 | 1,53,241 | 0.21 |
Motilal Oswal BSE Healthcare ETF | 0.04 | 1,608 | 0.12 |
Bandhan BSE Healthcare Index Fund - Direct (G) | 0.02 | 884 | 0.12 |
Bandhan BSE Healthcare Index Fund - Regular (G) | 0.02 | 884 | 0.12 |
Groww Nifty Total Market Index Fund-Direct (G) | 0.02 | 796 | 0.01 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 273.67 283.79 |
Week Low/High (₹) | 273.35 300.00 |
Month Low/High (₹) | 213.00 308.00 |
Year Low/High (₹) | 133.00 308.00 |
All time Low/High (₹) | 46.45 396.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -0.78% | -0.86% | -2.55 | -2.43% |
1 Month | 25.36% | 25.67% | 2.11 | 1.84% |
3 Month | 51.21% | 51.45% | -4.77 | -5.76% |
6 Month | 60.74% | 60.75% | 2.43 | 1.85% |
1 Year | 72.05% | 71.89% | 10.89 | 11.65% |
3 Year | 34.02% | 34.02% | 38.95 | 41.02% |
Chairman (Non-Executive) : Janmejay R Vyas
Whole-time Director : Deohooti J Vyas
Managing Director & CFO : Arpit J Vyas
Independent Director : Subir Kumar Das
Independent Director : Rajendra S Shah
Company Sec. & Compli. Officer : Shrima Dave
Independent Director : Maitri K Mehta
Registered Office: Dishman Corporate House, Iscon-Bopal Road Ambli,Ahmedabad,Gujarat-380058 Ph: 91-2717-400102/124
1. What's the Dishman Carbogen Amcis Ltd share price today?
Dishman Carbogen Amcis Ltd share price was Rs 276.25 at 04:01 PM IST on 19th Dec 2024. Dishman Carbogen Amcis Ltd share price was down by 2.42% from the previous closing price of Rs 283.10. Dishman Carbogen Amcis Ltd share price trend:
2. How can I quickly analyse the performance of the Dishman Carbogen Amcis Ltd stock?
The performance of the Dishman Carbogen Amcis Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Dishman Carbogen Amcis Ltd?
Dishman Carbogen Amcis Ltd has a market capitalisation of Rs 4,332 crore.
4. What is Dishman Carbogen Amcis Ltd's 52-week high/low share price?
The Dishman Carbogen Amcis Ltd’s 52-week high share price is Rs 307.80 and 52-week low share price is Rs 132.75.
5. Is the Dishman Carbogen Amcis Ltd profitable?
On a consolidated basis, Dishman Carbogen Amcis Ltd reported a profit of Rs 14.25 crore on a total income of Rs 117.22 crore for the quarter ended 2024. For the year ended Sep 2024, Dishman Carbogen Amcis Ltd had posted a profit of Rs 33.09 crore on a total income of Rs 795.69 crore.
6. Which are Dishman Carbogen Amcis Ltd’s peers in the Health care sector?
Dishman Carbogen Amcis Ltd’s top 5 peers in the Health care sector are Morepen Labs., Sequent Scien., Gufic BioScience, Dishman Carbogen, Advanced Enzyme, Aarti Drugs, RPG LifeScience..
7. Who owns how much in Dishman Carbogen Amcis Ltd?
Key changes to the Dishman Carbogen Amcis Ltd shareholding are as follows: